MedTrace Logo

Premedication Simethione Improves Visibility During Bowel Cleansing for Colonoscopy

NCT02540239 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 590

Last updated 2016-04-19

No results posted yet for this study

Summary

To evaluate the efficacy, visibility of low volume polyethyleneglycol-simeticone (2-LPEG-S) for colonoscopy.

Conditions

  • Bowel Preparation Scale
  • the Amount of Air Bubble
  • Adenoma Detection Rate

Interventions

DRUG

2L PEG

DRUG

2L PEG+simethicone

Sponsors & Collaborators

  • First Affiliated Hospital of Zhejiang University

    collaborator OTHER

  • Sir Run Run Shaw Hospital

    collaborator OTHER

  • Tongji Hospital

    collaborator OTHER

  • Qilu Hospital of Shandong University

    collaborator OTHER

  • Zhongda Hospital

    collaborator OTHER

  • Jinan Military General Hospital

    collaborator OTHER

  • First Hospital of China Medical University

    collaborator OTHER

  • Changhai Hospital

    lead OTHER

Principal Investigators

  • LI ZHAO SHEN, M.D · Changhai Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2016-02-29
Completion
2016-04-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02540239 on ClinicalTrials.gov